These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9657130)

  • 21. Evaluation of serum-free culture conditions able to support the ex vivo expansion and engraftment of human hematopoietic stem cells in the human-to-sheep xenograft model.
    Almeida-Porada G; Brown RL; MacKintosh FR; Zanjani ED
    J Hematother Stem Cell Res; 2000 Oct; 9(5):683-93. PubMed ID: 11091492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The in vitro and in vivo effects of stem cell factor on human hematopoiesis.
    Hoffman R; Tong J; Brandt J; Traycoff C; Bruno E; McGuire BW; Gordon MS; McNiece I; Srour EF
    Stem Cells; 1993 Jul; 11 Suppl 2():76-82. PubMed ID: 7691331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations.
    Jordan CT; Yamasaki G; Minamoto D
    Exp Hematol; 1996 Sep; 24(11):1347-55. PubMed ID: 8862447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture.
    Simmons PJ; Aylett GW; Niutta S; To LB; Juttner CA; Ashman LK
    Exp Hematol; 1994 Feb; 22(2):157-65. PubMed ID: 7507857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells.
    Traycoff CM; Abboud MR; Laver J; Brandt JE; Hoffman R; Law P; Ishizawa L; Srour EF
    Exp Hematol; 1994 Feb; 22(2):215-22. PubMed ID: 7507862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-cycle kinetics and VSV-G pseudotyped retrovirus-mediated gene transfer in blood-derived CD34+ cells.
    Agrawal YP; Agrawal RS; Sinclair AM; Young D; Maruyama M; Levine F; Ho AD
    Exp Hematol; 1996 May; 24(6):738-47. PubMed ID: 8635530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor-beta regulates the cell cycle status of interleukin-3 (IL-3) plus IL-1, stem cell factor, or IL-6 stimulated CD34+ human hematopoietic progenitor cells through different cell kinetic mechanisms depending on the applied stimulus.
    Lardon F; Snoeck HW; Nijs G; Lenjou M; Peetermans ME; Rodrigus I; Berneman ZN; Van Bockstaele DR
    Exp Hematol; 1994 Aug; 22(9):903-9. PubMed ID: 7520393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia maintains and interleukin-3 reduces the pre-colony-forming cell potential of dividing CD34(+) murine bone marrow cells.
    Ivanovic Z; Belloc F; Faucher JL; Cipolleschi MG; Praloran V; Dello Sbarba P
    Exp Hematol; 2002 Jan; 30(1):67-73. PubMed ID: 11823039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mpl ligand (MGDF) alone and in combination with stem cell factor (SCF) promotes proliferation and survival of human megakaryocyte, erythroid and granulocyte/macrophage progenitors.
    Rasko JE; O'Flaherty E; Begley CG
    Stem Cells; 1997; 15(1):33-42. PubMed ID: 9007220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of IL-6/sIL-6R on ex vivo expansion of human cord blood derived CD34+ cells].
    Feng JF; Zhuang M; Zhu LJ; Sheng ZL; Zhu YQ; Li CP
    Ai Zheng; 2004 Jun; 23(6):715-8. PubMed ID: 15191679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta.
    Veiby OP; Jacobsen FW; Cui L; Lyman SD; Jacobsen SE
    J Immunol; 1996 Oct; 157(7):2953-60. PubMed ID: 8816402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.
    Slanicka Krieger M; Nissen C; Manz CY; Toksoz D; Lyman SD; Wodnar-Filipowicz A
    Exp Hematol; 1998 May; 26(5):365-73. PubMed ID: 9590652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The in vitro growth of a cord blood-derived cell population enriched for CD34
    Muñiz-Rivera-Cambas A; Flores-Guzmán P; Mayani H
    Cytotherapy; 2018 Nov; 20(11):1345-1354. PubMed ID: 30322708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic myelogenous leukaemia CD34+ cells exit G0/G1 phases of cell cycle more rapidly than normal marrow CD34+ cells.
    Traycoff CM; Halstead B; Rice S; McMahel J; Srour EF; Cornetta K
    Br J Haematol; 1998 Aug; 102(3):759-67. PubMed ID: 9722304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell cycle distribution of primitive haematopoietic cells stimulated in vitro and in vivo.
    Zhang XW; Audet J; Piret JM; Li YX
    Cell Prolif; 2001 Oct; 34(5):321-30. PubMed ID: 11591179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asymmetric cell divisions in hematopoietic stem cells.
    Brümmendorf TH; Dragowska W; Lansdorp PM
    Ann N Y Acad Sci; 1999 Apr; 872():265-72; discussion 272-3. PubMed ID: 10372129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of hematopoietic stem cells using a composite approach.
    Nagare RP; Sneha S; Ramesh S; Ganesan TS
    Int J Biochem Cell Biol; 2019 Apr; 109():82-89. PubMed ID: 30776444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.